|
1.
|
Parkin DM, Bray FI and Devesa SS: Cancer
burden in the year 2000. The global picture. Eur J Cancer. 37(Suppl
8): S4–S66. 2001.PubMed/NCBI
|
|
2.
|
Cao C, Zhang YM, Wang R, Sun SF, Chen ZB,
Ma HY, Yu YM, Ding QL, Shu LH and Deng ZC: Excision repair cross
complementation group 1 polymorphisms and lung cancer risk: a
meta-analysis. Chin Med J (Engl). 124:2203–2208. 2011.PubMed/NCBI
|
|
3.
|
Yang L, Yang G, Zhou M, Smith M, Ge H,
Boreham J, Hu Y, Peto R, Wang J and Chen Z: Body mass index and
mortality from lung cancer in smokers and nonsmokers: a nationally
representative prospective study of 220,000 men in China. Int J
Cancer. 125:2136–2143. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Gandara D, Narayan S, Lara PN Jr, Goldberg
Z, Davies A, Lau DH, Mack P, Gumerlock P and Vijayakumar S:
Integration of novel therapeutics into combined modality therapy of
locally advanced non-small cell lung cancer. Clin Cancer Res.
11:5057s–5062s. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Yin M, Liao Z, Huang YJ, Liu Z, Yuan X,
Gomez D, Wang LE and Wei Q: Polymorphisms of homologous
recombination genes and clinical outcomes of non-small cell lung
cancer patients treated with definitive radiotherapy. PLoS One.
6:e200552011. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Yang P, Allen MS, Aubry MC, Wampfler JA,
Marks RS, Edell ES, Thibodeau S, Adjei AA, Jett J and Deschamps C:
Clinical features of 5,628 primary lung cancer patients: experience
at Mayo Clinic from 1997 to 2003. Chest. 128:452–462. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Cullen MH, Billingham LJ, Woodroffe CM,
Chetiyawardana AD, Gower NH, Joshi R, Ferry DR, Rudd RM, Spiro SG,
Cook JE, et al: Mitomycin, ifosfamide, and cisplatin in
unresectable non-small-cell lung cancer: effects on survival and
quality of life. J Clin Oncol. 17:3188–3194. 1999.PubMed/NCBI
|
|
8.
|
Bi N, Yang M, Zhang L, Chen X, Ji W, Ou G,
Lin D and Wang L: Cyclooxygenase-2 genetic variants are associated
with survival in unresectable locally advanced non-small cell lung
cancer. Clin Cancer Res. 16:2383–2390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Gupta A, Srivastava S, Prasad R, Natu SM,
Mittal B, Negi MP and Srivastava AN: Oxidative stress in non-small
cell lung cancer patients after chemotherapy: association with
treatment response. Respirology. 15:349–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Loft S, Svoboda P, Kawai K, Kasai H,
Sørensen M, Tjønneland A, Vogel U, Møller P, Overvad K and
Raaschou-Nielsen O: Association between 8-oxo-7,8-dihydroguanine
excretion and risk of lung cancer in a prospective study. Free
Radic Biol Med. Oct 20–2011.(E-pub ahead of print).
|
|
11.
|
Lawless MW, O’Byrne KJ and Gray SG:
Oxidative stress induced lung cancer and COPD: opportunities for
epigenetic therapy. J Cell Mol Med. 13:2800–2821. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Shadel GS and Clayton DA: Mitochondrial
DNA maintenance in vertebrates. Annu Rev Biochem. 66:409–435. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
DiMauro S and Schon EA: Mitochondrial DNA
mutations in human disease. Am J Med Genet. 106:18–26. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Beal MF: Mitochondia, free radicals, and
neurodegeneration. Curr Opin Neurobiol. 6:661–666. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Lightowlers RN, Chinnery PF, Turnbull DM
and Howell N: Mammalian mitochondrial genetics: heredity,
heteroplasmy and disease. Trends Genet. 13:450–455. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Wallace DC: Mouse models for mitochondrial
disease. Am J Med Genet. 106:71–93. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Fliss MS, Usadel H, Caballero OL, Wu L,
Buta MR, Eleff SM, Jen J and Sidransky D: Facile detection of
mitochondrial DNA mutations in tumors and bodily fluids. Science.
287:2017–2019. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Nomoto S, Yamashita K, Koshikawa K, Nakao
A and Sidransky D: Mitochondrial D-loop mutation as clonal markers
in multicentric hepatocellular carcimona and plasma. Clin Cancer
Res. 8:481–487. 2002.PubMed/NCBI
|
|
19.
|
Mambo E, Gao X, Cohen Y, Guo Z, Talalay P
and Sidransky D: Electrophile and oxidant damage of mitochondrial
DNA leading to rapid evolution of homoplasmic mutations. Proc Natl
Acad Sci USA. 100:1838–1843. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Yoneyama H, Hara T, Kato Y, Yamori T,
Matsuura ET and Koike K: Nucleotide sequence variation is frequent
in the mitochondrial DNA displacement loop region of individual
human tumor cells. Mol Cancer Res. 3:14–20. 2005.PubMed/NCBI
|
|
21.
|
Jakupciak JP, Maragh S, Markowitz ME,
Greenberg AK, Hoque MO, Maitra A, Barker PE, Wagner PD, Rom WN,
Srivastava S, Sidransky D and O’Connell CD: Performance of
mitochondrial DNA mutations detecting early stage cancer. BMC
Cancer. 8:2852008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Nashikawa M, Nishiguchi S, Shiomi S,
Tamori A, Koh N, Takeda T, Kubo S, Hirohashi K, Kinoshita H, Sato E
and Inoue M: Somatic mutation of mitochondrial DNA in cancerous and
noncancerous liver tissue in individuals with hepatocellular
carcinoma. Cancer Res. 61:1843–1845. 2001.PubMed/NCBI
|
|
23.
|
Sanchez-Cespedes M, Parrella P, Nomoto S,
Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T and
Koch WM: Identification of a mononucleotide repeat as a major
target for mitochondrial DNA alterations in human tumors. Cancer
Res. 61:7015–7019. 2001.PubMed/NCBI
|
|
24.
|
Taanman JW: The mitochondrial genome:
structure, transcription, translation and replication. Biochim
Biophys Acta. 1410:103–123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Zhang R, Zhang F, Wang C, Wang S, Shiao YH
and Guo Z: Identification of sequence polymorphism in the D-loop
region of mitochondrial DNA as a risk factor for hepatocellular
carcinoma with distinct etiology. J Exp Clin Cancer Res.
29:1302010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Wang C, Zhang F, Fan H, Peng L, Zhang R,
Liu S and Guo Z: Sequence polymorphisms of mitochondrial D-loop and
hepatocellular carcinoma outcome. Biochem Biophys Res Commun.
406:493–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Navaglia F, Basso D, Fogar P, Sperti C,
Greco E, Zambon CF, Stranges A, Falda A, Pizzi S, Parenti A,
Pedrazzoli S and Plebani M: Mitochondrial DNA D-loop in pancreatic
cancer: somatic mutations are epiphenomena while the germline 16519
T variant worsens metabolism and outcome. Am J Clin Pathol.
126:593–601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Wang L, Bamlet WR, de Andrade M, Boardman
LA, Cunningham JM, Thibodeau SN and Petersen GM: Mitochondrial
genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol
Biomarkers Prev. 16:1455–1459. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Wang L, McDonnell SK, Hebbring SJ,
Cunningham JM, St Sauver J, Cerhan JR, Isaya G, Schaid DJ and
Thibodeau SN: Polymorphisms in mitochondrial genes and prostate
cancer risk. Cancer Epidemiol Biomarkers Prev. 17:3558–3566. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Zhang R, Wang R, Zhang F, Wu C, Fan H, Li
Y, Wang C and Guo Z: Single-nucleotide polymorphisms in the
mitochondrial displacement loop and outcome of esophageal squamous
cell carcinoma. J Exp Clin Cancer Res. 29:1552010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Bandy B and Davison AJ: Mitochondrial
mutations may increase oxidative stress: implications for
carcinogenesis and aging? Free Radic Biol Med. 8:523–539. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Gille JJ and Joenje H: Cell culture models
for oxidative stress: superoxide and hydrogen peroxide versus
normobaric hyperoxia. Mutat Res. 275:405–414. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Shigenaga MK, Hagen TM and Ames BN:
Oxidative damage and mitochondrial decay in aging. Proc Natl Acad
Sci USA. 91:10771–10778. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Dement GA, Maloney SC and Reeves R:
Nuclear HMGA1 nonhistone chromatin proteins directly influence
mitochondrial transcription, maintenance, and function. Exp Cell
Res. 313:77–87. 2007. View Article : Google Scholar
|
